Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease

Alan Cheng, Darshan Dalal, Barry J. Fetics, Piamsook Angkeow, David D. Spragg, Hugh Calkins, Gordon F. Tomaselli, Ronald D. Berger

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Ibutilide-Induced Changes in the Temporal Lability of Ventricular Repolarization. Introduction: Ibutilide has been shown to prolong repolarization times and increase the risk of ventricular tachyarrhythmias particularly in patients with structural heart disease. The mechanisms underlying its proarrhythmic effects remain incompletely understood. We sought to define the effects of ibutilide on the temporal lability of ventricular repolarization in patients with and without structural heart disease. Methods: Twenty-four patients referred for electrophysiology study underwent monophasic action potential (MAP) recordings in the right ventricle during sinus rhythm and random interval right atrial pacing (RIAP). Ibutilide was subsequently administered and the recordings repeated both in sinus rhythm and with RIAP. Digitized recordings were analyzed offline for calculation of the QT variability index (QTVI) based on surface ECG, and the MAP duration variability index (MAPDVI) based on the intracardiac MAP signal. Results: Of 24 patients enrolled, analyses were performed in 21 patients (mean age 59 ± 15 years, 38% women). In three patients, the data were not analyzed due to frequent premature ventricular complexes. Ibutilide resulted in significant changes in heart rate (mean difference: -7.4 ± 0.91 bpm, P < 0.0001) and the surface QT interval (mean difference: 59.6 ± 12.2 ms, P = 0.0001) during sinus rhythm. After ibutilide, QTVI remained unchanged from baseline during sinus rhythm but was significantly different in the setting of RIAP (mean difference: 0.345 ± 0.098, P = 0.0022). With subgroup analyses, these differences remained significant regardless of the presence or absence of heart disease. Conclusion: Ibutilide results in overall prolongation of ventricular repolarization and reductions in baseline sinus rates. Ibutilide increases temporal lability of repolarization only with enriched fluctuations in heart rate. (J Cardiovasc Electrophysiol, Vol. 20, pp. 873-879, August 2009)

Original languageEnglish (US)
Pages (from-to)873-879
Number of pages7
JournalJournal of Cardiovascular Electrophysiology
Volume20
Issue number8
DOIs
StatePublished - Aug 1 2009
Externally publishedYes

Fingerprint

Heart Diseases
Action Potentials
Heart Rate
Ventricular Premature Complexes
ibutilide
Electrophysiology
Tachycardia
Heart Ventricles
Electrocardiography

Keywords

  • Ibutilide
  • Monophasic action potential
  • QT interval
  • Torsades de pointes
  • Ventricular repolarization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease. / Cheng, Alan; Dalal, Darshan; Fetics, Barry J.; Angkeow, Piamsook; Spragg, David D.; Calkins, Hugh; Tomaselli, Gordon F.; Berger, Ronald D.

In: Journal of Cardiovascular Electrophysiology, Vol. 20, No. 8, 01.08.2009, p. 873-879.

Research output: Contribution to journalArticle

Cheng, Alan ; Dalal, Darshan ; Fetics, Barry J. ; Angkeow, Piamsook ; Spragg, David D. ; Calkins, Hugh ; Tomaselli, Gordon F. ; Berger, Ronald D. / Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease. In: Journal of Cardiovascular Electrophysiology. 2009 ; Vol. 20, No. 8. pp. 873-879.
@article{c2eb04570a4c4cdcb3423a033b006ab9,
title = "Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease",
abstract = "Ibutilide-Induced Changes in the Temporal Lability of Ventricular Repolarization. Introduction: Ibutilide has been shown to prolong repolarization times and increase the risk of ventricular tachyarrhythmias particularly in patients with structural heart disease. The mechanisms underlying its proarrhythmic effects remain incompletely understood. We sought to define the effects of ibutilide on the temporal lability of ventricular repolarization in patients with and without structural heart disease. Methods: Twenty-four patients referred for electrophysiology study underwent monophasic action potential (MAP) recordings in the right ventricle during sinus rhythm and random interval right atrial pacing (RIAP). Ibutilide was subsequently administered and the recordings repeated both in sinus rhythm and with RIAP. Digitized recordings were analyzed offline for calculation of the QT variability index (QTVI) based on surface ECG, and the MAP duration variability index (MAPDVI) based on the intracardiac MAP signal. Results: Of 24 patients enrolled, analyses were performed in 21 patients (mean age 59 ± 15 years, 38{\%} women). In three patients, the data were not analyzed due to frequent premature ventricular complexes. Ibutilide resulted in significant changes in heart rate (mean difference: -7.4 ± 0.91 bpm, P < 0.0001) and the surface QT interval (mean difference: 59.6 ± 12.2 ms, P = 0.0001) during sinus rhythm. After ibutilide, QTVI remained unchanged from baseline during sinus rhythm but was significantly different in the setting of RIAP (mean difference: 0.345 ± 0.098, P = 0.0022). With subgroup analyses, these differences remained significant regardless of the presence or absence of heart disease. Conclusion: Ibutilide results in overall prolongation of ventricular repolarization and reductions in baseline sinus rates. Ibutilide increases temporal lability of repolarization only with enriched fluctuations in heart rate. (J Cardiovasc Electrophysiol, Vol. 20, pp. 873-879, August 2009)",
keywords = "Ibutilide, Monophasic action potential, QT interval, Torsades de pointes, Ventricular repolarization",
author = "Alan Cheng and Darshan Dalal and Fetics, {Barry J.} and Piamsook Angkeow and Spragg, {David D.} and Hugh Calkins and Tomaselli, {Gordon F.} and Berger, {Ronald D.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1111/j.1540-8167.2009.01476.x",
language = "English (US)",
volume = "20",
pages = "873--879",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease

AU - Cheng, Alan

AU - Dalal, Darshan

AU - Fetics, Barry J.

AU - Angkeow, Piamsook

AU - Spragg, David D.

AU - Calkins, Hugh

AU - Tomaselli, Gordon F.

AU - Berger, Ronald D.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Ibutilide-Induced Changes in the Temporal Lability of Ventricular Repolarization. Introduction: Ibutilide has been shown to prolong repolarization times and increase the risk of ventricular tachyarrhythmias particularly in patients with structural heart disease. The mechanisms underlying its proarrhythmic effects remain incompletely understood. We sought to define the effects of ibutilide on the temporal lability of ventricular repolarization in patients with and without structural heart disease. Methods: Twenty-four patients referred for electrophysiology study underwent monophasic action potential (MAP) recordings in the right ventricle during sinus rhythm and random interval right atrial pacing (RIAP). Ibutilide was subsequently administered and the recordings repeated both in sinus rhythm and with RIAP. Digitized recordings were analyzed offline for calculation of the QT variability index (QTVI) based on surface ECG, and the MAP duration variability index (MAPDVI) based on the intracardiac MAP signal. Results: Of 24 patients enrolled, analyses were performed in 21 patients (mean age 59 ± 15 years, 38% women). In three patients, the data were not analyzed due to frequent premature ventricular complexes. Ibutilide resulted in significant changes in heart rate (mean difference: -7.4 ± 0.91 bpm, P < 0.0001) and the surface QT interval (mean difference: 59.6 ± 12.2 ms, P = 0.0001) during sinus rhythm. After ibutilide, QTVI remained unchanged from baseline during sinus rhythm but was significantly different in the setting of RIAP (mean difference: 0.345 ± 0.098, P = 0.0022). With subgroup analyses, these differences remained significant regardless of the presence or absence of heart disease. Conclusion: Ibutilide results in overall prolongation of ventricular repolarization and reductions in baseline sinus rates. Ibutilide increases temporal lability of repolarization only with enriched fluctuations in heart rate. (J Cardiovasc Electrophysiol, Vol. 20, pp. 873-879, August 2009)

AB - Ibutilide-Induced Changes in the Temporal Lability of Ventricular Repolarization. Introduction: Ibutilide has been shown to prolong repolarization times and increase the risk of ventricular tachyarrhythmias particularly in patients with structural heart disease. The mechanisms underlying its proarrhythmic effects remain incompletely understood. We sought to define the effects of ibutilide on the temporal lability of ventricular repolarization in patients with and without structural heart disease. Methods: Twenty-four patients referred for electrophysiology study underwent monophasic action potential (MAP) recordings in the right ventricle during sinus rhythm and random interval right atrial pacing (RIAP). Ibutilide was subsequently administered and the recordings repeated both in sinus rhythm and with RIAP. Digitized recordings were analyzed offline for calculation of the QT variability index (QTVI) based on surface ECG, and the MAP duration variability index (MAPDVI) based on the intracardiac MAP signal. Results: Of 24 patients enrolled, analyses were performed in 21 patients (mean age 59 ± 15 years, 38% women). In three patients, the data were not analyzed due to frequent premature ventricular complexes. Ibutilide resulted in significant changes in heart rate (mean difference: -7.4 ± 0.91 bpm, P < 0.0001) and the surface QT interval (mean difference: 59.6 ± 12.2 ms, P = 0.0001) during sinus rhythm. After ibutilide, QTVI remained unchanged from baseline during sinus rhythm but was significantly different in the setting of RIAP (mean difference: 0.345 ± 0.098, P = 0.0022). With subgroup analyses, these differences remained significant regardless of the presence or absence of heart disease. Conclusion: Ibutilide results in overall prolongation of ventricular repolarization and reductions in baseline sinus rates. Ibutilide increases temporal lability of repolarization only with enriched fluctuations in heart rate. (J Cardiovasc Electrophysiol, Vol. 20, pp. 873-879, August 2009)

KW - Ibutilide

KW - Monophasic action potential

KW - QT interval

KW - Torsades de pointes

KW - Ventricular repolarization

UR - http://www.scopus.com/inward/record.url?scp=70349247661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349247661&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8167.2009.01476.x

DO - 10.1111/j.1540-8167.2009.01476.x

M3 - Article

C2 - 19460072

AN - SCOPUS:70349247661

VL - 20

SP - 873

EP - 879

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 8

ER -